The Lumenis M22 combines intense pulsed light (IPL) with unique optimal pulse technology (OPT) for treatment of inflammatory ocular conditions, such as meibomian gland dysfunction (MGD), blepharitis, eyelid inflammation and eyelid telangiectasia. The technology can also treat the root cause of dry eye disease (DED) with MGD treatment.Visit BOC Ophthalmic Instruments’ ShowroomSTAND F14 BOC OPHTHALMIC INSTRUMENTSMore reading: Show & Tell Report
Forward thinking: paving a way to partnership with George & Matilda Eyecare
Early-career optometrist Thomas Ford has carved a path from rural practice to partnership with George & Matilda Eyecare, blending clinical...



